These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 26681196)

  • 1. Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer.
    Ock CY; Nam AR; Bang JH; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ; Oh DY
    Gastric Cancer; 2017 Jan; 20(1):164-174. PubMed ID: 26681196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic implication of antitumor immunity measured by the neutrophil-lymphocyte ratio and serum cytokines and angiogenic factors in gastric cancer.
    Ock CY; Nam AR; Lee J; Bang JH; Lee KH; Han SW; Kim TY; Im SA; Kim TY; Bang YJ; Oh DY
    Gastric Cancer; 2017 Mar; 20(2):254-262. PubMed ID: 27147244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma cytokine and angiogenic factor profiling identifies markers associated with tumor shrinkage in early-stage non-small cell lung cancer patients treated with pazopanib.
    Nikolinakos PG; Altorki N; Yankelevitz D; Tran HT; Yan S; Rajagopalan D; Bordogna W; Ottesen LH; Heymach JV
    Cancer Res; 2010 Mar; 70(6):2171-9. PubMed ID: 20215520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of the increase in the serum M30 and M65 values after chemotherapy and relationship between these values and clinicopathological factors in patients with advanced gastric cancer.
    Bilici A; Ustaalioglu BB; Ercan S; Seker M; Yilmaz BE; Orcun A; Gumus M
    Tumour Biol; 2012 Dec; 33(6):2201-8. PubMed ID: 22890829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum signature of hypoxia-regulated factors is associated with progression after induction therapy in head and neck squamous cell cancer.
    Byers LA; Holsinger FC; Kies MS; William WN; El-Naggar AK; Lee JJ; Hu J; Lopez A; Tran HT; Yan S; Du Z; Ang KK; Glisson BS; Raso MG; Wistuba II; Myers JN; Hong WK; Papadimitrakopoulou V; Lippman SM; Heymach JV
    Mol Cancer Ther; 2010 Jun; 9(6):1755-63. PubMed ID: 20530716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A plasma cytokine and angiogenic factor (CAF) analysis for selection of bevacizumab therapy in patients with metastatic colorectal cancer.
    Bai L; Wang F; Zhang DS; Li C; Jin Y; Wang DS; Chen DL; Qiu MZ; Luo HY; Wang ZQ; Li YH; Wang FH; Xu RH
    Sci Rep; 2015 Dec; 5():17717. PubMed ID: 26620439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinoma.
    Zurita AJ; Jonasch E; Wang X; Khajavi M; Yan S; Du DZ; Xu L; Herynk MH; McKee KS; Tran HT; Logothetis CJ; Tannir NM; Heymach JV
    Ann Oncol; 2012 Jan; 23(1):46-52. PubMed ID: 21464158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of targetable angiogenic and growth factors in patients undergoing resection for gastric and gastroesophageal junction cancers.
    Park DJ; Yoon C; Thomas N; Ku GY; Janjigian YY; Kelsen DP; Ilson DH; Goodman KA; Tang LH; Strong VE; Coit DG; Yoon SS
    Ann Surg Oncol; 2014 Apr; 21(4):1130-7. PubMed ID: 24370903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokines and angiogenic factors in patients with metastatic renal cell carcinoma treated with interferon-alpha: association of pretreatment serum levels with survival.
    Montero AJ; Diaz-Montero CM; Millikan RE; Liu J; Do KA; Hodges S; Jonasch E; McIntyre BW; Hwu P; Tannir N
    Ann Oncol; 2009 Oct; 20(10):1682-7. PubMed ID: 19541791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TEM1 expression in cancer-associated fibroblasts is correlated with a poor prognosis in patients with gastric cancer.
    Fujii S; Fujihara A; Natori K; Abe A; Kuboki Y; Higuchi Y; Aizawa M; Kuwata T; Kinoshita T; Yasui W; Ochiai A
    Cancer Med; 2015 Nov; 4(11):1667-78. PubMed ID: 26336878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.
    Sun Z; Zhang N
    World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble PD-L1 Expression in Circulation as a Predictive Marker for Recurrence and Prognosis in Gastric Cancer: Direct Comparison of the Clinical Burden Between Tissue and Serum PD-L1 Expression.
    Shigemori T; Toiyama Y; Okugawa Y; Yamamoto A; Yin C; Narumi A; Ichikawa T; Ide S; Shimura T; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Ohi M; Araki T; Kusunoki M
    Ann Surg Oncol; 2019 Mar; 26(3):876-883. PubMed ID: 30565045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The distinct signatures of VEGF and soluble VEGFR2 increase prognostic implication in gastric cancer.
    Ock CY; Nam AR; Bang JH; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ; Oh DY
    Am J Cancer Res; 2015; 5(11):3376-88. PubMed ID: 26807318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct patterns of cytokine and angiogenic factor modulation and markers of benefit for vandetanib and/or chemotherapy in patients with non-small-cell lung cancer.
    Hanrahan EO; Lin HY; Kim ES; Yan S; Du DZ; McKee KS; Tran HT; Lee JJ; Ryan AJ; Langmuir P; Johnson BE; Heymach JV
    J Clin Oncol; 2010 Jan; 28(2):193-201. PubMed ID: 19949019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low expression of DLC1 is predictive of poor therapeutic efficiency of fluoropyrimidine and oxaliplatin as adjuvant chemotherapy in gastric cancer.
    Su Y; Lin L; Zhang J; Jiang Y; Pan C; Sun L; Duan J; Liao W
    Mol Med Rep; 2015 Oct; 12(4):5771-9. PubMed ID: 26239822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of soluble programmed cell death ligand 1 as a prognostic factor on the first-line treatment of metastatic or recurrent gastric cancer.
    Takahashi N; Iwasa S; Sasaki Y; Shoji H; Honma Y; Takashima A; Okita NT; Kato K; Hamaguchi T; Yamada Y
    J Cancer Res Clin Oncol; 2016 Aug; 142(8):1727-38. PubMed ID: 27256004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of serum vascular endothelial growth factor per platelet count in unresectable advanced gastric cancer patients.
    Seo HY; Park JM; Park KH; Kim SJ; Oh SC; Kim BS; Kim YH; Kim JS
    Jpn J Clin Oncol; 2010 Dec; 40(12):1147-53. PubMed ID: 20647232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prognostic Value of Signet-Ring Cell Histology in Resected Gastric Adenocarcinoma.
    Postlewait LM; Squires MH; Kooby DA; Poultsides GA; Weber SM; Bloomston M; Fields RC; Pawlik TM; Votanopoulos KI; Schmidt CR; Ejaz A; Acher AW; Worhunsky DJ; Saunders N; Swords D; Jin LX; Cho CS; Winslow ER; Cardona K; Staley CA; Maithel SK
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S832-9. PubMed ID: 26156656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative Plasma Fibrinogen and Serum Albumin Score Is an Independent Prognostic Factor for Resectable Stage II-III Gastric Cancer.
    Wu M; Pan Y; Jia Z; Wang Y; Yang N; Mu J; Zhou T; Guo Y; Jiang J; Cao X
    Dis Markers; 2019; 2019():9060845. PubMed ID: 31781312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological characteristics and outcomes in stage I-III mucinous gastric adenocarcinoma: a retrospective study at a single medical center.
    Hsu JT; Wang CW; Le PH; Wu RC; Chen TH; Chiang KC; Lin CJ; Yeh TS
    World J Surg Oncol; 2016 Apr; 14():123. PubMed ID: 27112436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.